Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.


Enhanced thrombin/PAR1 activity promotes G-CSF- and AMD3100-induced mobilization of hematopoietic stem and progenitor cells via NO upregulation

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Fig. 1: HSPC mobilization involves thrombin/PAR1/NO axis activity.
Fig. 2: Thrombin inhibition reduces EPCR shedding, facilitating HSPC homing and engraftment.


  1. 1.

    Aronovich A, Nur Y, Shezen E, Rosen C, Zlotnikov Klionsky Y, Milman I, et al. A novel role for factor VIII and thrombin/PAR1 in regulating hematopoiesis and its interplay with the bone structure. Blood. 2013;122:2562–71.

    CAS  Article  Google Scholar 

  2. 2.

    Borkowska S, Suszynska M, Mierzejewska K, Ismail A, Budkowska M, Salata D, et al. Novel evidence that crosstalk between the complement, coagulation and fibrinolysis proteolytic cascades is involved in mobilization of hematopoietic stem/progenitor cells (HSPCs). Leukemia. 2014;28:2148–54.

    CAS  Article  Google Scholar 

  3. 3.

    Gur-Cohen S, Itkin T, Chakrabarty S, Graf C, Kollet O, Ludin A, et al. PAR1 signaling regulates the retention and recruitment of EPCR-expressing bone marrow hematopoietic stem cells. Nat Med. 2015;21:1307–17.

    Article  Google Scholar 

  4. 4.

    Nevo N, Zuckerman T, Gur-Cohen S, Kollet O, Avemaria F, Shpall EJ, et al. PAR1 expression predicts clinical G-CSF CD34(+) HSPC mobilization and repopulation potential in transplanted patients. Hemasphere. 2019;3:e288.

    Article  Google Scholar 

  5. 5.

    Nguyen TS, Lapidot T, Ruf W. Extravascular coagulation in hematopoietic stem and progenitor cell regulation. Blood. 2018;132:123–31.

    CAS  Article  Google Scholar 

  6. 6.

    Aicher A, Heeschen C, Mildner-Rihm C, Urbich C, Ihling C, Technau-Ihling K, et al. Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat Med. 2003;9:1370–6.

    CAS  Article  Google Scholar 

  7. 7.

    Zhang Y, Wittner M, Bouamar H, Jarrier P, Vainchenker W, Louache F. Identification of CXCR4 as a new nitric oxide-regulated gene in human CD34+ cells. Stem Cells. 2007;25:211–9.

    CAS  Article  Google Scholar 

  8. 8.

    Xu D, Yang M, Capitano M, Guo B, Liu S, Wan J, et al. Pharmacological activation of nitric oxide signaling promotes human hematopoietic stem cell homing and engraftment. Leukemia. 2020;35:229–34.

  9. 9.

    Adamiak M, Abdelbaset-Ismail A, Moore JBT, Zhao J, Abdel-Latif A, Wysoczynski M, et al. Inducible nitric oxide synthase (iNOS) is a novel negative regulator of hematopoietic stem/progenitor cell trafficking. Stem Cell Rev Rep. 2017;13:92–103.

    CAS  Article  Google Scholar 

  10. 10.

    Stettner N, Rosen C, Bernshtein B, Gur-Cohen S, Frug J, Silberman A, et al. Induction of nitric-oxide metabolism in enterocytes alleviates colitis and inflammation-associated colon cancer. Cell Rep. 2018;23:1962–76.

    CAS  Article  Google Scholar 

  11. 11.

    Fares I, Chagraoui J, Lehnertz B, MacRae T, Mayotte N, Tomellini E, et al. EPCR expression marks UM171-expanded CD34(+) cord blood stem cells. Blood. 2017;129:3344–51.

    CAS  Article  Google Scholar 

  12. 12.

    Denham JW, Hauer-Jensen M. The radiotherapeutic injury-a complex ‘wound’. Radiother Oncol. 2002;63:129–45.

    Article  Google Scholar 

  13. 13.

    Hendrikx PJ, Martens CM, Hagenbeek A, Keij JF, Visser JW. Homing of fluorescently labeled murine hematopoietic stem cells. Exp Hematol. 1996;24:129–40.

    CAS  PubMed  Google Scholar 

  14. 14.

    Steidl U, Kronenwett R, Rohr UP, Fenk R, Kliszewski S, Maercker C, et al. Gene expression profiling identifies significant differences between the molecular phenotypes of bone marrow-derived and circulating human CD34+ hematopoietic stem cells. Blood. 2002;99:2037–44.

    CAS  Article  Google Scholar 

  15. 15.

    LeBlanc R, Roy J, Demers C, Vu L, Cantin G. A prospective study of G-CSF effects on hemostasis in allogeneic blood stem cell donors. Bone Marrow Transplant. 1999;23:991–6.

    CAS  Article  Google Scholar 

Download references


This work was partially supported by the Israel Science Foundation (ISF), a joint grant from the Israel Science Foundation (ISF) and the National Natural Science Foundation of China (NSFC), Minerva Foundation and the Federal German Ministry for Education and Research, Steven B. Rubenstein Research Fund, Weizmann Stem Cell Institute, The WIS Moross Integrated Cancer Center, Asher Pertman and Wayne Pertman, and the Estate of David Levinson.

Author information




NN and OK reviewed literature, designed and conducted experiments, analyzed results, and wrote the paper. SGC, LAOM, FA, MB, EKM, MH, PC, and SB designed and performed experiments, analyzed data, and reviewed the manuscript. WR participated in designing experiments and reviewed the manuscript. TL reviewed literature, designed the study concept, guided the research, and wrote the paper.

Corresponding authors

Correspondence to Tsvee Lapidot or Orit Kollet.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Nevo, N., Ordonez-Moreno, LA., Gur-Cohen, S. et al. Enhanced thrombin/PAR1 activity promotes G-CSF- and AMD3100-induced mobilization of hematopoietic stem and progenitor cells via NO upregulation. Leukemia (2021).

Download citation


Quick links